Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://mattiequsy675470.is-blog.com/42874700/tirzepatide-a-promising-new-treatment-for-obesity